184 related articles for article (PubMed ID: 8512815)
21. [31P magnetic resonance spectroscopy(MRS) study in basal ganglia of patients with Parkinson's disease].
Kudo M; Mizuno Y; Morita H; Miyazaki M
Nihon Rinsho; 1997 Jan; 55(1):255-61. PubMed ID: 9014460
[TBL] [Abstract][Full Text] [Related]
22. Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study.
Mann DV; Lam WW; Magnus Hjelm N; So NM; Yeung DK; Metreweli C; Lau WY
Gut; 2002 Jan; 50(1):118-22. PubMed ID: 11772978
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.
Chung YL; Troy H; Banerji U; Jackson LE; Walton MI; Stubbs M; Griffiths JR; Judson IR; Leach MO; Workman P; Ronen SM
J Natl Cancer Inst; 2003 Nov; 95(21):1624-33. PubMed ID: 14600095
[TBL] [Abstract][Full Text] [Related]
24. Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS.
Otsuka H; Harada M; Koga K; Nishitani H
Magn Reson Imaging; 1999 Feb; 17(2):283-90. PubMed ID: 10215484
[TBL] [Abstract][Full Text] [Related]
25. Effect of ethanol and fructose on liver metabolism: a dynamic 31Phosphorus magnetic resonance spectroscopy study in normal volunteers.
Boesch C; Elsing C; Wegmüller H; Felblinger J; Vock P; Reichen J
Magn Reson Imaging; 1997; 15(9):1067-77. PubMed ID: 9364953
[TBL] [Abstract][Full Text] [Related]
26. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.
Komoroski RA; Pearce JM; Mrak RE
Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399
[TBL] [Abstract][Full Text] [Related]
27. Phosphorus-31 nuclear magnetic resonance in vivo spectroscopy of human liver during hepatitis A virus infection.
Yamane Y; Umeda M; O'uchi T; Mitsushima T; Nakata K; Nagataki S
Dig Dis Sci; 1994 Jan; 39(1):33-8. PubMed ID: 8281864
[TBL] [Abstract][Full Text] [Related]
28. Gluconeogenesis and the protection of hepatic intracellular pH during diabetic ketoacidosis in rats.
Beech JS; Williams SR; Cohen RD; Iles RA
Biochem J; 1989 Nov; 263(3):737-44. PubMed ID: 2512912
[TBL] [Abstract][Full Text] [Related]
29. Decreased energy and phosphorylation status in the liver of lung cancer patients with weight loss.
Leij-Halfwerk S; Dagneli PC; Kappert P; Oudkerk M; Sijens PE
J Hepatol; 2000 Jun; 32(6):887-92. PubMed ID: 10898308
[TBL] [Abstract][Full Text] [Related]
30. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy.
Meyerhoff DJ; Karczmar GS; Valone F; Venook A; Matson GB; Weiner MW
Invest Radiol; 1992 Jun; 27(6):456-64. PubMed ID: 1318873
[TBL] [Abstract][Full Text] [Related]
31. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study.
Kalra R; Wade KE; Hands L; Styles P; Camplejohn R; Greenall M; Adams GE; Harris AL; Radda GK
Br J Cancer; 1993 May; 67(5):1145-53. PubMed ID: 8494715
[TBL] [Abstract][Full Text] [Related]
32. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation.
Lyng H; Olsen DR; Petersen SB; Rofstad EK
NMR Biomed; 1995 Apr; 8(2):65-71. PubMed ID: 7547188
[TBL] [Abstract][Full Text] [Related]
33. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging.
Li CW; Negendank WG; Murphy-Boesch J; Padavic-Shaller K; Brown TR
NMR Biomed; 1996 Jun; 9(4):141-55. PubMed ID: 9015801
[TBL] [Abstract][Full Text] [Related]
34. [Phosphorus 31-magnetic resonance spectroscopic studies of animal liver after extracorporeal shock wave lithotripsy].
Yokota H; Matoba M; Tatsuta N; Tonami H; Okimura T; Yamamoto I
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):934-41. PubMed ID: 1508653
[TBL] [Abstract][Full Text] [Related]
35. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
36. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy.
Richardson AJ; Cox IJ; Sargentoni J; Puri BK
NMR Biomed; 1997 Oct; 10(7):309-14. PubMed ID: 9471121
[TBL] [Abstract][Full Text] [Related]
37. 1H magnetic resonance imaging and 31P magnetic resonance spectroscopy in experimental filariasis.
Shukla-Dave A; Fatma N; Roy R; Srivastava S; Chatterjee RK; Govindaraju V; Viswanathan AK; Raghunathan P
Magn Reson Imaging; 1997; 15(10):1193-8. PubMed ID: 9408140
[TBL] [Abstract][Full Text] [Related]
38. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
[TBL] [Abstract][Full Text] [Related]
39. Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy.
Schlemmer HP; Sawatzki T; Sammet S; Dornacher I; Bachert P; van Kaick G; Waldherr R; Seitz HK
J Hepatol; 2005 May; 42(5):752-9. PubMed ID: 15826726
[TBL] [Abstract][Full Text] [Related]
40. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
